This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Investival Showcase Europe
Life Science Executive Partnering
Monday 17th November 2025Old Billingsgate, London, UK

Present your innovations

Present your company in-person to potential investors and partners at the LSX Investival Showcase on one of the focuses showcase stages.

This opportunity is for Biotech, Pharma, Drug Delivery, Diagnostic, Medical Device, Healthtech, and Techbio companies actively developing products, and platform companies supporting drug discovery and design for which they own the IP.

Who could present?

Biotech

Companies with a therapeutic (molecular) pipeline, developing new drugs and therapies to improve health and quality of life. E.g. Vaccines, GLP-1s, cancer drugs.

Techbio

Sophisticated technologies (AI/ML/Software) to solve biological problems. e.g. Automated drug discovery.

Pharmatech

Digital tools, software, and innovative technologies such as AI, blockchain, cloud computing, and machine learning applied across the healthcare product lifecycle in pharma. e.g. Clinical trial automation/monitoring, AI or software in R&D, Regulatory/Quality Assurance, manufacturing.

Medtech

Hardware and software designed to diagnose, treat, and monitor patients. Used directly in patient care to improve the healthcare journey in clinical settings. e.g. MRIs, drug delivery systems, robotic surgery, thermometers.

Digital

Incorporating digital care programs and technologies into healthcare and society, making medicine more personalised and precise. A focus on personal health management, prevention, and monitoring rather than diagnosis or treatment. e.g. Telehealth, wearables, health apps, electronic health records.